Policy, Law, Economics and Politics - Deepening Democracy through Access to Information
This privately-owned website is operated and maintained by Creamer Media
We have detected that the browser you are using is no longer supported. As a result, some content may not display correctly.
We suggest that you upgrade to the latest version of any of the following browsers:
close notification
28 May 2017
Article by: Reuters
Photo: Reuters
Embed Code Close
  Related social media

The US on Thursday approved $526-million aid to Tanzania over the coming year to expand the roll out of life-prolonging anti-retroviral drugs to people infected with HIV, the virus that causes AIDS.   

Some 1.4-million Tanzanians are estimated to be living with HIV in the nation of around 50-million people, with about 850 000 of them currently on anti-retrovirals (ARVs).   

"This support will bring the total number of Tanzanians on HIV treatment up to 1.2-million," the US Embassy in Tanzania said in a statement.   

The funds were donated through the US President's Emergency Plan for AIDS Relief (PEPFAR), the world's largest provider of AIDS-fighting medicine. The programme has been credited with saving millions of lives around the world.    The financial assistance represents a 12 percent increase over last year’s budget and will also support HIV testing for 8.6-million Tanzanians and provide treatment to an estimated 360 000 people who newly test positive with the virus.   

The funds will also support the care and treatment of orphans and vulnerable children and voluntary medical male circumcision to further prevent HIV transmission.

Edited by: Reuters
Comment Guidelines (150 word limit)
  Topics on this page
Industry Term
Medical Condition
Medical Treatment
Online Publishers Association